Cocrystal Pharma (COCP) Capital Expenditures (2010 - 2024)
Cocrystal Pharma (COCP) posted Capital Expenditures of $8000.0 for Q1 2024, down 86.44% sequentially from $59000.0 in Q4 2023, and down 82.22% YoY from $45000.0 in Q2 2023.
Cocrystal Pharma (COCP) Capital Expenditures (2010 - 2024) Analysis & Trends
Cocrystal Pharma has reported Capital Expenditures for 14 years, with the latest figure at $8000.0 in Q1 2024.
- Quarterly Capital Expenditures fell 82.22% year-over-year to $8000.0 in Q1 2024, while the trailing twelve-month figure through Dec 2024 was $8000.0 (down 93.22% YoY) and the FY2025 annual result came in at $12000.0, up 50.0% from the prior year.
- Capital Expenditures eased to $8000.0 in Q1 2024 per COCP's latest filing, from $59000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $127000.0 in Q2 2020 and troughed at $1000.0 in Q4 2020.
- A 5-year average of $33076.9 and a median of $15000.0 in 2021 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2020 and 2021: Capital Expenditures soared 3075.0% in 2020, then sank 88.19% in 2021.
- Over 5 years, Capital Expenditures stood at $1000.0 in 2020, then jumped by 700.0% to $8000.0 in 2021, then jumped by 50.0% to $12000.0 in 2022, then soared by 391.67% to $59000.0 in 2023, then slumped by 86.44% to $8000.0 in 2024.
- According to Business Quant data, Capital Expenditures over the past three periods registered $8000.0, $59000.0, and $14000.0 for Q1 2024, Q4 2023, and Q2 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 251.02 Mn |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 8,000.00 |
| Mar 31, 2024 | 8,000.00 |
| Dec 31, 2023 | 59,000.00 |
| Dec 31, 2023 | 59,000.00 |
| Jun 30, 2023 | 14,000.00 |
| Jun 30, 2023 | 14,000.00 |
| Mar 31, 2023 | 45,000.00 |
| Mar 31, 2023 | 45,000.00 |
| Dec 31, 2022 | 12,000.00 |
| Dec 31, 2022 | 12,000.00 |
| Dec 31, 2021 | 8,000.00 |
| Dec 31, 2021 | 8,000.00 |
| Sep 30, 2021 | 4,000.00 |
| Sep 30, 2021 | 4,000.00 |
| Jun 30, 2021 | 15,000.00 |
| Jun 30, 2021 | 15,000.00 |
| Mar 31, 2021 | 25,000.00 |
| Mar 31, 2021 | 25,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Dec 31, 2020 | 1,000.00 |